估算门诊衣原体和淋病治疗的直接医疗成本和生产力损失。
Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment.
机构信息
From the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA.
出版信息
Sex Transm Dis. 2021 Feb 1;48(2):e18-e21. doi: 10.1097/OLQ.0000000000001240.
Abstract
We used 2016-2017 administrative claims data to calculate the direct medical cost and productivity loss per diagnosed case of chlamydia and gonorrhea treatment. In 2018 US dollars, the direct cost per diagnosed case was $151 for chlamydia (n = 9180) and $85 for gonorrhea (n = 3048); productivity loss was $206 (n = 31) and $246 (n = 7), respectively, among those missing work seeking care.
摘要
我们使用 2016-2017 年的行政索赔数据来计算每例确诊的衣原体和淋病治疗的直接医疗费用和生产力损失。以 2018 年美元计算，每例确诊病例的直接成本分别为衣原体 151 美元（n = 9180）和淋病 85 美元（n = 3048）；那些因工作而缺勤寻求治疗的人，生产力损失分别为 206 美元（n = 31）和 246 美元（n = 7）。
相似文献
1
Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment.估算门诊衣原体和淋病治疗的直接医疗成本和生产力损失。
Sex Transm Dis. 2021 Feb 1;48(2):e18-e21. doi: 10.1097/OLQ.0000000000001240.
2
Estimates of the Lifetime Productivity Costs of Chlamydia, Gonorrhea, and Syphilis in the United States.美国淋病、衣原体和梅毒的终生生产力成本估计。
Sex Transm Dis. 2024 Oct 1;51(10):635-640. doi: 10.1097/OLQ.0000000000001973. Epub 2024 Apr 19.
3
Estimating Recommended Gonorrhea and Chlamydia Treatment Rate Using Linked Medical Claims, Prescription, and Laboratory Data in US Private Settings.利用美国私人医疗环境下的医疗索赔、处方和实验室数据，估算淋球菌和衣原体推荐治疗率。
Sex Transm Dis. 2021 Mar 1;48(3):167-173. doi: 10.1097/OLQ.0000000000001290.
4
The cost-effectiveness of an outreach clinical model in the management and prevention of gonorrhea and chlamydia among Chinese female sex workers in Hong Kong.一种外展临床模式在香港中国女性性工作者淋病和衣原体管理及预防中的成本效益
Sex Transm Dis. 2006 Apr;33(4):220-7. doi: 10.1097/01.olq.0000187300.58733.a6.
5
Factors associated with non-guideline-adherent treatment for gonorrhea and chlamydia among outpatient prescriptions in the Unites States.美国门诊处方中与淋病和衣原体非指南依从性治疗相关的因素。
Int J STD AIDS. 2022 Jun;33(7):694-700. doi: 10.1177/09564624221097751. Epub 2022 Apr 29.
6
Undertreatment of chlamydia and gonorrhea among pregnant women in the emergency department.急诊科孕妇沙眼衣原体和淋病治疗不足的情况。
Int J STD AIDS. 2020 Feb;31(2):166-173. doi: 10.1177/0956462419880379. Epub 2019 Dec 22.
7
A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.同日性传播感染检测及左炔诺孕酮宫内节育系统放置后盆腔感染风险的前瞻性评估
Am J Obstet Gynecol. 2016 Nov;215(5):599.e1-599.e6. doi: 10.1016/j.ajog.2016.05.017. Epub 2016 May 12.
8
[Clinical study of gonorrhea and Chlamydia infections].[淋病和衣原体感染的临床研究]
Nihon Rinsho. 1986 Sep;44(9):2072-7.
9
Chlamydia and Gonorrhea.衣原体和淋病。
Ann Intern Med. 2021 Oct;174(10):ITC145-ITC160. doi: 10.7326/AITC202110190. Epub 2021 Oct 12.
10
Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005-2006.性传播感染的经济负担：伊利诺伊州青少年和年轻人中衣原体、淋病和梅毒的发病率和直接医疗费用，2005-2006 年。
Sex Transm Dis. 2009 Oct;36(10):629-36. doi: 10.1097/OLQ.0b013e3181a96d23.
引用本文的文献
1
Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022.2022年商业保险理赔数据中18至49岁孕妇的梅毒筛查
Sex Transm Dis. 2025 May 1;52(5):295-303. doi: 10.1097/OLQ.0000000000002089. Epub 2025 Mar 4.
2
Adolescent Chlamydia Screening in Pediatric Primary Care: A Quality Improvement Project.儿科初级保健中的青少年衣原体筛查：一项质量改进项目。
J Adv Nurs. 2024 Nov 4. doi: 10.1111/jan.16595.
3
Relative Cost and Infectious Days Averted Associated With Rapid Gonorrhea and Chlamydia Testing Among Men Who Have Sex With Men.男性性工作者中快速淋病和衣原体检测相关的相对成本和避免感染天数。
Sex Transm Dis. 2024 Jun 1;51(6):388-392. doi: 10.1097/OLQ.0000000000001956.
4
Estimates of the Lifetime Productivity Costs of Chlamydia, Gonorrhea, and Syphilis in the United States.美国淋病、衣原体和梅毒的终生生产力成本估计。
Sex Transm Dis. 2024 Oct 1;51(10):635-640. doi: 10.1097/OLQ.0000000000001973. Epub 2024 Apr 19.
5
Vaccine value profile for Neisseria gonorrhoeae.淋病奈瑟菌疫苗的价值概况。
Vaccine. 2024 Jul 25;42(19S1):S42-S69. doi: 10.1016/j.vaccine.2023.01.053. Epub 2023 Dec 13.
6
Pathogenic NKT cells attenuate urogenital chlamydial clearance and enhance infertility.致病 NKT 细胞减弱泌尿生殖道沙眼衣原体清除并增强不孕。
Scand J Immunol. 2023 May;97(5):e13263. doi: 10.1111/sji.13263. Epub 2023 Mar 15.
7
Design, Biological Evaluation, and Computer-Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents.二氢噻嗪类化合物作为选择性抗衣原体药物的设计、生物学评价和计算机辅助分析。
J Med Chem. 2023 Feb 9;66(3):2116-2142. doi: 10.1021/acs.jmedchem.2c01894. Epub 2023 Jan 25.
8
as a Current Health Problem: Challenges and Opportunities.作为一个当前的健康问题：挑战与机遇
Diagnostics (Basel). 2022 Jul 25;12(8):1795. doi: 10.3390/diagnostics12081795.
9
Acclimation to Nutritional Immunity and Metal Intoxication Requires Zinc, Manganese, and Copper Homeostasis in the Pathogenic .适应营养免疫和金属中毒需要病原体中的锌、锰和铜的动态平衡。
Front Cell Infect Microbiol. 2022 Jun 30;12:909888. doi: 10.3389/fcimb.2022.909888. eCollection 2022.
10
Lifetime Medical Costs of Genital Herpes in the United States: Estimates From Insurance Claims.美国生殖器疱疹的终身医疗成本：来自保险理赔的估计
Sex Transm Dis. 2021 Apr 1;48(4):266-272. doi: 10.1097/OLQ.0000000000001371.
Zotero 插件